Spontaneous Urticaria

• FDA approval · 2020-04-29
  FDA Approved: CURIST ALLERGY RELIEF — Original Application (Little Pharma, Inc.)

  FDA approved Little Pharma, Inc.'s CURIST ALLERGY RELIEF as the original ANDA for levocetirizine dihydrochloride 5 mg, a generic tablet for …

• FDA approval · 2010-12-21
  FDA Approved: XOLAIR — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for XOLAIR (omalizumab) submitted by Genentech, Inc., resulting in updated labeling.

• FDA approval · 2010-01-04
  FDA Approved: XOLAIR — Supplemental Application (Genentech, Inc.)

  FDA approved Genentech's supplemental application for XOLAIR (omalizumab), updating its labeling via a supplemental approval.

• FDA approval · 2007-07-02
  FDA Approved: XOLAIR — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for XOLAIR (omalizumab) from Genentech, Inc., to modify/expand its labeling.